Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Gabapentin in Patients at Clinical Risk for Psychosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02557945
Recruitment Status : Suspended (This study is temporarily suspended due to COVID-19)
First Posted : September 23, 2015
Last Update Posted : February 25, 2021
Sponsor:
Information provided by (Responsible Party):
Scott Small, New York State Psychiatric Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 31, 2021
Estimated Study Completion Date : May 31, 2022